Home > Healthcare > Pharmaceuticals > Finished Drug Form > Nasal Spray Market

Nasal Spray Market Share

Report ID: GMI5687
Published Date: May 2023
Report Format: PDF

Download Free Sample

Nasal Spray Market Share

The key players in nasal spray market are:

Bayer AG
Novartis AG
GlaxoSmithKline plc
ADAPt Pharma Inc
Cipla Inc
AbbVie Inc
Aurena Laboratories
Sun Pharmaceutical Industries Ltd
Viatris Inc and Leeford Healthcare Limited.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches, etc. to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for nasal spray was more than USD 24 billion in 2022 and will register over 6.5% CAGR between 2023 and 2032, with growing prevalence of chronic respiratory diseases and nasal disorders.

The steroids nasal spray segment value was over USD 7.5 billion in 2022 as they aid in decreasing nasal inflammation, mucus production, and nasal congestion, improving sinus drainage.

Retail pharmacy end-users is anticipated to depict remarkable growth rate from 2023 to 2032, owing to better awareness and utilization of nasal sprays to treat conditions like runny nose, nasal congestion, swelling, and others.

North America nasal spray market accounted for the highest share in 2022, as a result of the increased prevalence of diseases like sinusitis, allergic rhinitis, nasal polyps, cold, and other respiratory diseases in the region.